天美传媒

Abstract

The integration of telemedicine and mobile health (mHealth) technologies into diabetes management represents a transformative shift in patient care, offering innovative solutions to enhance monitoring, treatment adherence, and overall health outcomes. This abstract explores the convergence of telemedicine and mHealth in the context of diabetes management, highlighting the potential benefits, challenges, and future directions. Telemedicine facilitates real-time consultations between patients and healthcare providers, overcoming geographical barriers and improving access to specialist care. mHealth applications, including glucose monitoring apps and digital insulin management tools, empower patients with continuous data tracking and personalized feedback. Evidence suggests that these technologies can lead to better glycemic control, increased patient engagement, and reduced healthcare costs. However, challenges such as data security, technology access disparities, and the need for regulatory frameworks remain. Future research should focus on optimizing these technologies, addressing interoperability issues, and exploring their impact on long-term health outcomes. Overall, the integration of telemedicine and mHealth has the potential to revolutionize diabetes management by fostering a more connected, proactive, and patient-centered approach to care.